CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

  • Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.